BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29747779)

  • 1. Association of serum nesfatin-1 concentrations with atrial fibrillation.
    Duan XL; Li L; Li YN
    Kaohsiung J Med Sci; 2018 Jun; 34(6):348-351. PubMed ID: 29747779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum adropin with the presence of atrial fibrillation and atrial remodeling.
    Wang B; Xue Y; Shang F; Ni S; Liu X; Fan B; Wang H
    J Clin Lab Anal; 2019 Feb; 33(2):e22672. PubMed ID: 30239031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of serum and vitreous nesfatin-1 concentrations with diabetic retinopathy.
    Dai R; Deng G; Sun Z; Liu Z; Qian Y; Han Y
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 28079928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and synovial fluid nesfatin-1 concentration is associated with radiographic severity of knee osteoarthritis.
    Zhang Y; Shui X; Lian X; Wang G
    Med Sci Monit; 2015 Apr; 21():1078-82. PubMed ID: 25872767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.
    Ding S; Qu W; Dang S; Xie X; Xu J; Wang Y; Jing A; Zhang C; Wang J
    Med Sci Monit; 2015 Apr; 21():987-91. PubMed ID: 25841171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Omentin-1 Concentrations with the Presence of Atrial Fibrillation.
    Tao S; Huang YQ; Cai AP; Huang C; Zhang Y; Tang ST; Yu XJ; Zhou D; Tan N; Feng YQ
    Med Sci Monit; 2016 Dec; 22():4749-4754. PubMed ID: 27915353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum macrophage migration inhibitory factor is correlated with atrial fibrillation.
    Wan C; Li Z
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28407372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?
    Saldanha JF; Carrero JJ; Lobo JC; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B; Mafra D
    Regul Pept; 2012 Jan; 173(1-3):82-5. PubMed ID: 22036920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.
    Shen P; Han Y; Cai B; Wang Y
    Sleep Breath; 2015 May; 19(2):515-22. PubMed ID: 25056666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of serum nesfatin-1 in patients with preeclampsia.
    Zhang C; Wang Y; Wang Y; Li J; Liu R; Liu H
    Biomarkers; 2014 Aug; 19(5):402-6. PubMed ID: 24857385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
    Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
    Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.
    Zhang Z; Li L; Yang M; Liu H; Boden G; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):91-5. PubMed ID: 22020667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients.
    Han X; Chen C; Cheng G; Xie C; Yang M; Shou X; Sun C
    Cytokine; 2015 May; 73(1):176-80. PubMed ID: 25766411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nesfatin-1 levels on paroxysmal supraventricular tachycardia.
    Celik A; Gurger M; Can Ç; Balin M; Gul E; Kobat MA; Gumusay U; Sahan M; Bursal KB; Celiker I; Aydin S; Aydin S
    J Investig Med; 2013 Jun; 61(5):852-5. PubMed ID: 23524986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between nesfatin-1 and carotid artery stenosis.
    Kuyumcu A
    Scand Cardiovasc J; 2018 Dec; 52(6):328-334. PubMed ID: 30599786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum nesfatin-1 levels in endometriosis.
    Şengül Ö; Dilbaz B; Halıcı Z; Ferah I; Çadırcı E; Yılmaz F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():34-7. PubMed ID: 24702902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nesfatin-1 and fat mass in cystic fibrosis.
    Cohen RI; Ginsberg N; Tsang D; Wann LC; Ye X; Liu SF
    Respiration; 2013; 86(4):312-7. PubMed ID: 23306670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch.
    St-Pierre DH; Martin J; Shimizu H; Tagaya Y; Tsuchiya T; Marceau S; Biertho L; Bastien M; Caron-Cantin SM; Simard S; Richard D; Cianflone K; Poirier P
    Peptides; 2016 Dec; 86():6-12. PubMed ID: 27681383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 levels in patients with slow coronary flow.
    Kuyumcu MS; Kuyumcu A; Yayla Ç; Özbay MB; Alagöz M; Ünal S; Açar B; Özeke Ö; Samur G
    Kardiol Pol; 2018; 76(2):401-405. PubMed ID: 29131290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
    Ünal K; Yüksel RN; Turhan T; Sezer S; Yaylaci ET
    Psychiatry Res; 2018 Mar; 261():45-49. PubMed ID: 29278806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.